On Probiotic, Dental Caries, and Orthodontic Patients
Effect of Drops Containing Lactobacillus Reuteri (DSM 17938 and ATCC PTA 4659) on Plaque Acidogenicity and Other Caries Related Variables in Orthodontic Patients
1 other identifier
interventional
28
1 country
1
Brief Summary
To investigate the short term effect of probiotic oil on plaque acidogenicity among orthodontic patients. Shortage on testing the effect of probiotic on Orthodontic patients can be seen on litterateurs making a gap of whether is product of help in preventing dental caries or not ?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2020
CompletedOctober 19, 2020
October 1, 2020
1 month
October 5, 2020
October 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of Probiotic oil (drops) on plaque acidogenicity (pH) among orthodontic patients.
Changes in the plaque pH (acidic or alkaline) is an important factor among others in the cares process, in which an acidic environment will help the bacteria to accumulate along the tooth surface and starting the caries lesions. So, considering the plaque pH as a clinical variable to show the probiotic effect is considered to be of great value.
3 weeks
Secondary Outcomes (2)
Effect of Probiotics on Dental plaque
3 weeks
Effect of Probiotics on Saliva
3 weeks
Study Arms (2)
Active Probiotic
EXPERIMENTALProbiotic contain active microorganism
Placebo Probiotic
PLACEBO COMPARATORProbiotic with no active microorganism
Interventions
Lactobacillus Reuteri (DSM 17938 and ATCC PTA 4659
Eligibility Criteria
You may qualify if:
- Subjects undergoing bimaxillary fixed orthodontic treatment
- Number of S. mutans counts (\>10.000 CFU/ml)
- Permanent dentition
- months into the treatment (study from Sweden by Andrea)
- Medically healthy
- Not taking any medication
- Ability to understand the nature of the study and sign the consent form
You may not qualify if:
- Cleft lip and palate patients as well as handicapped and patients with mental impairments
- Systemic diseases or conditions that could interfere with our study (diabetes, immunosuppression diseases, pregnancy or ongoing therapy).
- History of probiotics/anti-inflammatory drugs taken during the last 4 weeks prior to baseline examination
- Local or general antimicrobial substances taken during the last 4 prior weeks prior to baseline examination
- Habitual consumers of xylitol chewing gums
- No active or untreated carious lesions and reported daily tooth brushing habit using fluoridated toothpaste
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gothenburg university
Gothenburg, SE-405 30, Sweden
Related Publications (1)
Alforaidi S, Bresin A, Almosa N, Lehrkinder A, Lingstrom P. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients. BMC Microbiol. 2021 Oct 6;21(1):271. doi: 10.1186/s12866-021-02310-2.
PMID: 34615458DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- 3rd party will be involved in labeling the test and placebo samples
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2020
First Posted
October 19, 2020
Study Start
November 1, 2020
Primary Completion
December 1, 2020
Study Completion
December 21, 2020
Last Updated
October 19, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- As soon as we finish with the data collection and the manuscript writing, the data will be published online.
This research planned for publication